Published in
Baishideng Publishing Group, World Journal of Gastroenterology, 15(15), p. 1843, 2009
DOI: 10.3748/wjg.15.1843
Links
- ORCID
- Baishideng Publishing Group
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: A cohort study
Journal article published in 2009 by
Marco Bertini,
Pasquale Petruzzi,
Michele Bertoni,
Rodolfo Sacco 
,
Irene Bargellini,
Giampaolo Bresci,
Graziana Federici,
Antonio Scaramuzzino,
Luigi Gambardella,
Emanuele Tumino,
Salvatore Metrangolo,
Giuseppe Parisi,
Alessandro Silvestri,
Antonio Romano,
Claudio Vignali
and other authors.
,
Irene Bargellini,
Giampaolo Bresci,
Graziana Federici,
Antonio Scaramuzzino,
Luigi Gambardella,
Emanuele Tumino,
Salvatore Metrangolo,
Giuseppe Parisi,
Alessandro Silvestri,
Antonio Romano,
Claudio Vignali
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
Abstract
AIM: To prospectively evaluate the short and long term clinical impact of selective transarterial chemoembolization (TACE) on liver function in patients with hepatocellular carcinoma (HCC). To assess side effects in relation to treatments. To analyze the overall survival and HCC progression free survival probability.